top of page
Docteur Joseph MONSONEGO
Gynécologie - Colposcopie
Pathologies génitales à papillomavirus
Publications du Docteur Monsonego
Infection à papillomavirus humains (HPV) et pathologies associées, dépistage, prévention, diagnostic et traitement.
1. Epidémiologie HPV
VIN VAIN HPV PREVALENCE
Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Young Women
(Obstet Gynecol Jan 18,2018)
Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease.
(Cancer Epidemiol Biomarkers Prev October 2014 23:10 1997-2008)
Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
(Vaccine 30, 2012, 5215–5221)
Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial.
(Gynecol Oncol, January 2015)
Prévalence des génotypes d’HPV chez les femmes en France:implications pour le dépistage et la vaccination.
(Gynécol. Obstét. Fertil, 2013;41:305–313)
Prévalence de l’infection à HPV en France, impact attendu de la vaccination et du dépistage pour la prévention du cancer du col utérin.
(Vaccine, 30, 2012, 5215‐522)
2. Dépistage du cancer du col
Dépistage du cancer du col utérin : un tournant ?
Gynécologie Obstétrique Pratique 28/11/2017
Cytologie en phase liquide dans le cadre d’un dépistage primaire du cancer du col utérin : une étude multicentrique.
(Gynécol Obstét Fertil 2001 ; 29 : 1-9)
Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.
Int. J. Cancer: 129, 691–701 (2011)
Liquid-based cytology for primary cervical cancer screening: a multi-centre study.
Br J Cancer. 2001 Feb 2;84(3):360-6.
3. Vaccination HPV
Vaccination HPV dans la vraie vie : dix années d’expérience
mt Médecine de la Reproduction, Gynécologie
Endocrinologie, vol. 18, n◦ 1, janvier-février-mars 2016
End of study safety, immunogenicity, and efficacy of quadrivalent (types 6, 11, 16, 18) recombinant vaccine in adult women 24 to 45 years of age.
Br J Cancer. 2011 Jun 28;105(1):28-37
Prévention du cancer du col utérin : enjeux et perspectives de la vaccination antipapillomavirus
(Gynecol Obstet Fertil, 2006 Mar ; 34 (3):189-201)
Profil de sécurité des vaccins papillomavirus : mise au point
(2015)
CNGOF 2015
Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Vaccine 28 (2010) 8065–8072
4. Optimisation de la colposcopie
Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening
(The FASE Study). (Gynecologic Oncology 125, 2012, 175–180)
Performance of the Roche AMPLICOR Human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
(Gynecologic Oncology 99, 2005, 160 – 168)
Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
(Int J Gynecol Cancer. 2006 Mar-Apr;16(2):591-8 )
Colposcopie : apport du test HPV en pratique clinique.
(Gynecol Obstet Fertil. 2004 Jan;32(1):62-74)
5. Transmission / Rôle de l'homme
Male circumcision for prevention of oncogenic HPV infection — Author's reply.
Genital human papillomavirus infections: correlation of cytological, colposcopic and histological features with viral types in women and their male partners.
Genital infection with HPV in men: translating research into practice.
(Vaccine. 2011 Jan 17;29(4):624-8)
6. Perception des femmes
Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries.
Civil society: A critical new advocate for vaccination in Europe.
(Vaccine. 2011 Jan 17;29(4):624-8)
Perception et impact psychologique du frottis anormal en France. Résultats comparatifs d’une enquête européenne.
7. HPV / EUROGIN Roadmap - Consensus d'experts internationaux
Eurogin 2017 Roadmap: Triage strategies for the managment of HPV-positive women in cervical screening programs
Kate Cuschieri 1 , Guglielmo Ronco 2 , Attila Lorincz 3 , Laurie Smith4 , Gina Ogilvie5 , Lisa Mirabello6 , Francesca Carozzi7 , Heather Cubie8 , Nicolas Wentzensen6 , Peter Snijders9 , Marc Arbyn10, Joe Monsonego11 and Silvia Franceschi12
Int J Cancer. 2018 Aug 15;143(4):735-745
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines
Julia M.L. Brotherton1,2, Mark Jit3,4, Patti E. Gravitt5 , Marc Brisson6 , Aimee R. Kreimer 7 , Sara I. Pai8 , Carole Fakhry9 , Joseph Monsonego10 and Silvia Franceschi11
Int J Cancer. 2016 Aug 1;139(3):510-7
EUROGIN 2012 roadmap on Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix
Maura L. Gillison1 , Xavier Castellsague2 , Anil Chaturvedi3 , Marc T. Goodman4 , Peter Snijders5 , Massimo Tommasino6 , Marc Arbyn7,8 and Silvia Franceschi6
Int J Cancer. 2014 Feb 1;134(3):497-507
EUROGIN 2010 roadmap on cervical cancer prevention
Silvia Franceschi1 , Lynette Denny2 , Kathleen L. Irwin1*, Jose´ Jeronimo3 , Pier Luigi Lopalco4 , Joseph Monsonego5 , Julian Peto6 , Guglielmo Ronco7 , Peter Sasieni8 and Cosette M. Wheeler9
Int J Cancer. 2011 Jun 15;128(12):2765-74
EUROGIN 2007 roadmap on cervical cancer prevention
EUROGIN 2007
Patient Education Conference Report
Part 2
EUROGIN 2004
Recommendations guidelines
(Gynecol Oncol. 2005 Mar;96(3):830-9.)
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
Nicolas Wentzensen1 , Marc Arbyn2 , Johannes Berkhof3 , Mark Bower4 , Karen Canfell5 , Mark Einstein6 , Christopher Farley7 , Joseph Monsonego8 and Silvia Franceschi9
Int J Cancer. 2017 May 15;140(10):2192-2200
EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection
Anna R. Giuliano1 , Alan G. Nyitray2 , Aimee R. Kreimer 3 , Christine M. Pierce Campbell1 , Marc T. Goodman4 , Staci L. Sudenga1 , Joseph Monsonego5 and Silvia Franceschi6
Int J Cancer. 2015 Jun 15;136(12):2752-60
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
Marc Arbyn1*, Silvia de Sanjosé2 , Mona Saraiya3 , Mario Sideri4 , Joel Palefsky5 , Charles Lacey6 , Maura Gillison7 , Laia Bruni2 , Guglielmo Ronco8 , Nicolas Wentzensen9 , Julia Brotherton10, You-Lin Qiao11, Lynnette Denny12, Jacob Bornstein13, Laurent Abramowitz14, Anna Giuliano15, Massimo Tommasino16, Joseph Monsonego17
Int J Cancer. 2012 Nov 1;131(9):1969-82
EUROGIN 2008 roadmap on cervical cancer prevention
Silvia Franceschi1 , Jack Cuzick2 , Rolando Herrero3 , Joakim Dillner4 and Cosette M. Wheeler5*
Int J Cancer. 2009 Nov 15;125(10):2246-55
EUROGIN 2007
Patient Education Conference Report
Part 1
EUROGIN 2006
Recommendations guidelines
EUROGIN 2003
Recommendations guidelines
8. Test HPV
Detection of Human Papillomavirus Genotypes Among High-Risk Women: A Comparison of Hybrid Capture and Linear Array Tests.
(Sex Transm Dis. 2008 May;35(5):521-7)
Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
(Int J Gynecol Cancer. 2006 Mar-Apr;16(2):591-8 )
Immunocytochemistry in Liquid-Based Cytology Samples in Equivocal Pap Smears.
(Acta Cytol. 2007 Sep-Oct;51(5):755-66)
9. Recherche
Papillomavirus et cancer du col de l’utérus.
Estrogen and progesterone receptors in Cervical HPV related lesions.
(Gynecol Oncol. 2005 Mar;96(3):830-9.)
10. Condylome acuminé
Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France.
(Gynecol Obstet Fertil. 2007 Feb;35(2):107-13)
11. Anus
Cancer anal et papillomavirus humains : une pathologie en miroir de celle du cancer du col utérin.
(Gynécologie Obstétrique & Fertilité, 38 (2010) 250–254)
12. Cancers ORL/Multifocaux
Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review.
(Oral Oncology 67 (2017) 138–145)
Date de dernière mise à jour : jeudi 24 avril 2019
bottom of page